Analysis
4 Reasons Pfizer Could Be a Value Play You Can't Miss
Pfizer is in value territory, trading at just 10.74X forward earnings with a 5.88% annual dividend yield and over $10 billion in cash after selling $2.4 billion of its HLN position.
LONDON BROKER RATINGS: Goldman Sachs starts Barclays at 'buy'
Goldman Sachs raises AstraZeneca price target to 16,046 (15,914) pence - 'buy' Barclays raises Standard Chartered price target to 890 (850) pence - 'equal weight' Barclays raises Harbour Energy price ...
Armed robbery in Revesby19h
Haleon, Sydney Uni Propel Osteoarthritis Research
Haleon is teaming up with the University of Sydney to launch a five-year fellowship to research the efficacy of dietary supplements for ...
Major European Markets Close Higher
The major European markets closed higher higher on Monday as largely firm Asian markets and the recent upbeat jobs data from the U.S. helped keep investor sentiment ...